Mayne Pharma Group Limited logo

Mayne Pharma Group Limited

ASX:MYX.AX

Overview | Financials
Company Name Mayne Pharma Group Limited
Symbol MYX.AX
Currency AUD
Price 4.5
Market Cap 382,834,350
Dividend Yield 0%
52-week-range 2.75 - 7.46
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Shawn Patrick O'Brien B.Sc
Website https://www.maynepharma.com

An error occurred while fetching data.

About Mayne Pharma Group Limited

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract

Related Stocks

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IHL.AX

0.041 AUD

Sigma Healthcare Limited logo

Sigma Healthcare Limited

SIG.AX

1.42 AUD

Estia Health Limited logo

Estia Health Limited

EHE.AX

3.08 AUD

Opthea Limited logo

Opthea Limited

OPT.AX

0.64 AUD

Neuren Pharmaceuticals Limited logo

Neuren Pharmaceuticals Limited

NEU.AX

13.65 AUD

Mesoblast Limited logo

Mesoblast Limited

MSB.AX

0.92 AUD

Monash IVF Group Limited logo

Monash IVF Group Limited

MVF.AX

1.155 AUD

Oceania Healthcare Limited logo

Oceania Healthcare Limited

OCA.AX

0.665 AUD

Regis Healthcare Limited logo

Regis Healthcare Limited

REG.AX

5.73 AUD

AFT Pharmaceuticals Limited logo

AFT Pharmaceuticals Limited

AFP.AX

3.2 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD